Home » Reports » Broker Ratings » AstraZeneca plc 10.9% Potential Decrease Indicated by UBS
Analyst Broker Ratings

AstraZeneca plc 10.9% Potential Decrease Indicated by UBS

AstraZeneca plc using EPIC/TICKER code (LON:AZN) had its stock rating noted as ‘Downgrades’ with the recommendation being set at ‘SELL’ today by analysts at UBS. AstraZeneca plc are listed in the Health Care sector within UK Main Market. UBS have set their target price at 5400 GBX on its stock. This would indicate that the analyst believes there is a downside of -10.9% from today’s opening price of 6060 GBX. Over the last 30 and 90 trading days the company share price has decreased 152 points and increased 203 points respectively. The 52 week high share price is 6540 GBX while the 52 week low is 4825 GBX.

AstraZeneca plc has a 50 day moving average of 6,076.08 GBX and a 200 Day Moving Average share price is recorded at 5,923.34. There are currently 1,267,368,885 shares in issue with the average daily volume traded being 2,631,554. Market capitalisation for LON:AZN is £77,372,870,429 GBP.